ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000256603.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.022811304	Resistant
ENSG00000256603.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.01739103	Sensitive